BioSpace News Archive

CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler

CollPlant Biotechnologies announced that the U.S. Patent and Trademark Office has granted a patent that covers CollPlant’s photocurable dermal filler product candidate, being developed for the aesthetics market.

November 1, 2023
·
5 min read
Biotech Bay

Embolx Inc and Girlow USA Join Forces to Expand Distribution into South America

Embolx Inc, a leading provider of minimally invasive medical devices, is delighted to announce its international distribution partnership with Girlow USA, a renowned global distributor of advanced medical equipment.

November 1, 2023
·
2 min read
Genetown

PolyBio Research Foundation receives $15M for extended Long COVID research and clinical trials

PolyBio Research Foundation has announced a $15M gift from Kanro: a philanthropic fund to support scientific research established by Vitalik Buterin , co-founder of Ethereum.

November 1, 2023
·
3 min read
Business

Ginkgo Bioworks Announces Date of Third Quarter 2023 Results Presentation

Ginkgo Bioworks today announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2023, on Wednesday, November 8, 2023, beginning at 5:30 p.m. ET.

November 1, 2023
·
1 min read
Genetown

Tract Bio Announces Publication in American Journal of Respiratory and Critical Care Medicine Highlighting Stem Cell Variants Driving Lung Inflammation in Modulator-Treated Cystic Fibrosis Patients

Tract Bio today announced the publication of a research article in the American Journal of Respiratory and Critical Care Medicine (AJRCCM) highlighting the stem cell variants driving chronic lung inflammation in modulator-treated cystic fibrosis patients (CFTR modulators).

November 1, 2023
·
3 min read
Pharm Country

Sanofi launches “The 1 Pledge” movement to drive early screening for type 1 diabetes in the U.S.

Sanofi, a leader in diabetes care, launched “The 1 Pledge” movement, a nationwide education campaign urging families to get screened for type 1 diabetes so that those who will eventually be affected by the disease can begin to prepare as soon as possible.

November 1, 2023
·
9 min read
BioMidwest

UCB presents latest data from generalized myasthenia gravis portfolio at 2023 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session

UCB announced that it will be presenting results from across its portfolio in generalized myasthenia gravis at the American Association of Neuromuscular & Electrodiagnostic Medicine annual meeting and the Myasthenia Gravis Association of America Scientific Session taking place November 1-4, 2023.

November 1, 2023
·
25 min read
Business

cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer

cTRL Therapeutics today announced the appointment of Derrell D. Porter, M.D., as Chief Executive Officer.

November 1, 2023
·
3 min read
Drug Development

KAZIA THERAPEUTICS PROVIDES PRELIMINARY UPDATE FROM ONGOING PHASE 2 STUDY OF PAXALISIB IN PRIMARY CNS LYMPHOMA

Kazia Therapeutics Limited is pleased to provide a preliminary update from the ongoing investigator-initiated Phase 2 clinical trial (NCT04906096) evaluating paxalisib as monotherapy treatment in patients with relapsed/refractory primary central nervous system lymphoma (r/r PCNSL).

November 1, 2023
·
6 min read
South Rampart Pharma Expands Global Patent Portfolio with EU Approval for FDA Fast-Tracked SRP-001 for Pain

South Rampart Pharma, Inc. announced today the issuance of European Patent No. 3672938 by the European Patent Office (EPO) effective November 1, 2023.

November 1, 2023
·
5 min read